换一批
换一批Can Interim 18F-FDG PET or Diffusion-Weighted MRI Predict End-of-Treatment Outcome in FDG-Avid MALT Lymphoma After Rituximab-Based Therapy?: A Preliminary Study in 15 Patients.
第一作者：
Marius E,Mayerhoefer
第一单位：
From the *Department of Biomedical Imaging and Image-guided Therapy, †Department of Internal Medicine I, ‡Centre for Medical Physics and Biomedical Engineering, §Institute of Pathology, ∥Department of Internal Medicine III, and #Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria.
作者：
主题词
老年人(Aged);抗肿瘤药(Antineoplastic Agents);乳腺肿瘤(Breast Neoplasms);弥散磁共振成像(Diffusion Magnetic Resonance Imaging);眼肿瘤(Eye Neoplasms);女(雌)性(Female);氟脱氧葡萄糖F18(Fluorodeoxyglucose F18);人类(Humans);图像处理, 计算机辅助(Image Processing, Computer-Assisted);免疫疗法(Immunotherapy);泪器疾病(Lacrimal Apparatus Diseases);肺肿瘤(Lung Neoplasms);淋巴结(Lymph Nodes);淋巴瘤, B细胞, 边缘区(Lymphoma, B-Cell, Marginal Zone);男(雄)性(Male);中年人(Middle Aged);正电子发射断层显像术(Positron-Emission Tomography);预后(Prognosis);前瞻性研究(Prospective Studies);放射性药物(Radiopharmaceuticals);缓解诱导(Remission Induction);软组织肿瘤(Soft Tissue Neoplasms);脾肿瘤(Splenic Neoplasms);胃肿瘤(Stomach Neoplasms);治疗结果(Treatment Outcome)
DOI
10.1097/RLU.0000000000001395
PMID
27648705
发布时间
2018-12-02
- 浏览15
Clinical nuclear medicine
837-843页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
